EUROIMMUN and ALPCO-GeneProof partner for CE-IVD assays
The partnership will leverage EUROIMMUN's distribution network and ALPCO-GeneProof's molecular diagnostic technology.
The partnership will leverage EUROIMMUN's distribution network and ALPCO-GeneProof's molecular diagnostic technology.
The observational study will assess the clinical and workflow benefits of using Hyperfine’s Swoop system in detecting amyloid abnormalities in Alzheimer’s patients.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Acarix starts clinical workflow study for its AI-powered cardiac diagnostic
MMI secures FDA approval for Symani Surgical System
Cleerly touts new data for AI cardiovascular software
Avicenna.AI wins two FDA clearances for AI tools in CT scans